Biotech

Guggenheim Securities expands healthcare coverage

Guggenheim Securities has hired veteran equity analyst Charles "Tony" Butler as a managing director and senior equity analyst.

Butler will focus on the biotech/biopharma sector.
 
"Tony Butler brings our team a wealth of experience and a broad network of relationships in his industry," says Dante Ferrarie, senior managing director and head of equities at Guggenheim Securities. "His insights will further enhance the differentiated life sciences fundamental research that we offer our clients."
 
Guggenheim's healthcare research provides investors with a broad-based assessment of the industry and the policies that affect it.
 
Butler joins managing directors Louise Chen and Bret Holley in providing fundamental equity research on the leading companies in life sciences, while Rick Weissenstein leads Guggenheim's healthcare policy analysis team in Washington, DC. Guggenheim's healthcare policy offerings also include exclusive analysis by the Washington-based consulting firm Prevision Policy.
 
Butler was most recently a senior healthcare analyst at Lehman Brothers/Barclays for 18 years. Previously he was the head of healthcare research at Raymond James. 

Further reading



Upcoming events

3 days 17 hours from now - London
3 days 17 hours from now - Cartegena
3 days 17 hours from now - London
4 days 17 hours from now - Arizona
4 days 17 hours from now - Shanghai

Upcoming training